Infection Surveillance Solutions

Global Market Trajectory & Analytics

MCP12705

EXECUTIVE ENGAGEMENTS

POOL

2201
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

396
Interactions with Platform & by Email

PARTICIPANTS

66
Unique # Participated

VALIDATIONS

22
Responses Validated*

COMPANIES

41
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

68

PAGES

139

EDITION

6

PRICE

USD 4950

CODE

MCP12705


COMPETITIVE METRICS

COMPANY

D S N T

% *

Atlas Medical Software

Baxter International, Inc.

Becton, Dickinson and Company

Deb Group Ltd.

Gojo Industries, Inc.

Hygreen, Inc.

Rl Solutions

Truven Health Analytics

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Infection Surveillance Solutions estimated at US$391.3 Million in the year 2020, is projected to reach a revised size of US$946.9 Million by 2027, growing at aCAGR of 13.5% over the period 2020-2027. Software, one of the segments analyzed in the report, is projected to record 13.2% CAGR and reach US$600.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 14% CAGR for the next 7-year period.
The Infection Surveillance Solutions market in the U.S. is estimated at US$115.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$165.4 Million by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.8% and 11.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.

SELECT PLAYERS

Atlas Medical Software; Baxter International, Inc.; Becton, Dickinson and Company; Deb Group Ltd.; Gojo Industries, Inc.; Hygreen, Inc.; Premier, Inc.; Rl Solutions; Truven Health Analytics

SEGMENTS

» End-Use (Hospitals, Long-term Care Facilities, Other End-Uses) » Product (Software, Services)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Infection Surveillance Solutions Market on a Rapid Growth Trajectory
Cloud-based Infection Surveillance Solutions Witness Increased Demand
Asia-Pacific to be Fastest Growing Region, Driven by Increasing Cases of HAIs
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Incidence of HAIs, and Government Measures to Control them Drive the Growth of Infection Surveillance Solutions Market
Increasing Emphasis on Controlling Healthcare Expenditure Propels the Infection Surveillance Solutions Market
Rise in Number of Surgeries to Increase the Chances of HAI, thereby Driving the Demand for Infection Surveillance Solutions
Increasing Automation in Healthcare Units Offer Significant Opportunities for Market Growth
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Long-term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Long-term Care Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
Active Players in United States
USA Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
USA Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
CANADA
Active Players in Canada
Canada Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Canada Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
JAPAN
Active Players in Japan
Japan Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Japan Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
CHINA
Active Players in China
China Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
China Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Europe Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
FRANCE
Active Players in France
France Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
France Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
GERMANY
Active Players in Germany
Germany Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Germany Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
ITALY
Active Players in Italy
Italy Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Italy Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
UNITED KINGDOM
Active Players in United Kingdom
UK Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
UK Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
REST OF EUROPE
Active Players in Rest of Europe
Rest of Europe Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
ASIA-PACIFIC
Active Players in Asia-Pacific
Asia-Pacific Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
REST OF WORLD
Active Players in Rest of World
Rest of World Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Rest of World Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
Total Companies Profiled: 41

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com